Genetic basis of endocrine disease: pituitary tumor pathogenesis.
暂无分享,去创建一个
[1] S. Melmed. Pathogenesis of pituitary tumors. , 1999, Endocrinology and metabolism clinics of North America.
[2] S. Melmed,et al. Isolation and characterization of a pituitary tumor-transforming gene (PTTG). , 1997, Molecular endocrinology.
[3] S. Melmed,et al. Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation. , 1997, The Journal of clinical investigation.
[4] J. Dötsch,et al. Gs alpha mutation at codon 201 in pituitary adenoma causing gigantism in a 6-year-old boy with McCune-Albright syndrome. , 1996, The Journal of clinical endocrinology and metabolism.
[5] D. Nass,et al. Carcinoid tumors frequently display genetic abnormalities involving chromosome 11. , 1996, The Journal of clinical endocrinology and metabolism.
[6] K. Post,et al. Abundance and state of phosphorylation of the retinoblastoma gene product in human pituitary tumors , 1996, International journal of cancer.
[7] K. Post,et al. Frequent loss of the P16INK4a gene product in human pituitary tumors. , 1996, Cancer research.
[8] Nobuyuki Shishido,et al. Mice Lacking p27 Kip1 Display Increased Body Size, Multiple Organ Hyperplasia, Retinal Dysplasia, and Pituitary Tumors , 1996, Cell.
[9] James M. Roberts,et al. A Syndrome of Multiorgan Hyperplasia with Features of Gigantism, Tumorigenesis, and Female Sterility in p27 Kip1 -Deficient Mice , 1996, Cell.
[10] K. Manova-Todorova,et al. Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27 Kip1 , 1996, Cell.
[11] S. Melmed,et al. Structure of the thyrotrophin‐releasing hormone receptor in human pituitary adenomas , 1996, Clinical endocrinology.
[12] J. Battey,et al. Screening of candidate oncogenes in human thyrotroph tumors: absence of activating mutations of the G alpha q, G alpha 11, G alpha s, or thyrotropin-releasing hormone receptor genes. , 1996, The Journal of clinical endocrinology and metabolism.
[13] S. Melmed,et al. Heparin-binding secretory transforming gene (hst) facilitates rat lactotrope cell tumorigenesis and induces prolactin gene transcription. , 1996, The Journal of clinical investigation.
[14] S. Asa,et al. Targeting of transforming growth factor-alpha expression to pituitary lactotrophs in transgenic mice results in selective lactotroph proliferation and adenomas. , 1995, Endocrinology.
[15] T. Ohnishi,et al. Identification of alternatively spliced messenger ribonucleic acid encoding truncated growth hormone-releasing hormone receptor in human pituitary adenomas. , 1995, The Journal of clinical endocrinology and metabolism.
[16] P. Chanson,et al. The cyclic adenosine 3',5'-monophosphate-responsive factor CREB is constitutively activated in human somatotroph adenomas. , 1995, Molecular endocrinology.
[17] R. Weinberg,et al. The retinoblastoma protein and cell cycle control , 1995, Cell.
[18] S. Melmed,et al. Purine-binding factor (nm23) gene expression in pituitary tumors: marker of adenoma invasiveness. , 1995, The Journal of clinical endocrinology and metabolism.
[19] B. Scheithauer,et al. Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. , 1995, Cancer research.
[20] S. Asa,et al. Heterogenous in vivo and in vitro expression of basic fibroblast growth factor by human pituitary adenomas. , 1995, The Journal of clinical endocrinology and metabolism.
[21] D. Harrison,et al. G‐protein mutations in human pituitary adrenocorticotrophic hormone‐secreting adenomas , 1995, European journal of clinical investigation.
[22] S. Asa,et al. Membrane-anchored expression of transforming growth factor-alpha in human pituitary adenoma cells. , 1995, The Journal of clinical endocrinology and metabolism.
[23] S. Melmed,et al. The IGF‐I receptor sub‐membrane domain is intact in GH‐secreting pituitary tumours , 1995, Clinical endocrinology.
[24] P. Harris,et al. Gsα and Gi2α mutations in clinically non‐functioning pituitary tumours , 1994 .
[25] M. Brandi,et al. Circulating fibroblast growth factor-like autoantibodies in two patients with multiple endocrine neoplasia type 1 and prolactinoma. , 1994, The Journal of clinical endocrinology and metabolism.
[26] S. Lightman,et al. p53 gene mutations in pituitary adenomas: rare events , 1994, Clinical endocrinology.
[27] M. Meurisse,et al. Variable regions of chromosome 11 loss in different pathological tissues of a patient with the multiple endocrine neoplasia type I syndrome. , 1994, The Journal of clinical endocrinology and metabolism.
[28] S. Melmed,et al. Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineage. , 1994, The Journal of clinical endocrinology and metabolism.
[29] I. Mason. The ins and outs of fibroblast growth factors , 1994, Cell.
[30] K. Post,et al. Loss of heterozygosity at the retinoblastoma locus in human pituitary tumors , 1994, Cancer.
[31] B. Scheithauer,et al. H-ras mutations in human pituitary carcinoma metastases. , 1994, The Journal of clinical endocrinology and metabolism.
[32] A. Bradley,et al. Heterozygous Rb-1 delta 20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. , 1994, Oncogene.
[33] D. Gilliland,et al. Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus. , 1994, The Journal of clinical endocrinology and metabolism.
[34] C. Larsson,et al. Normal structural dopamine type 2 receptor gene in prolactin-secreting and other pituitary tumors. , 1994, The Journal of clinical endocrinology and metabolism.
[35] S. Melmed,et al. Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors. , 1994, The Journal of clinical endocrinology and metabolism.
[36] R. Thakker,et al. Molecular genetic studies of sporadic pituitary tumors. , 1994, The Journal of clinical endocrinology and metabolism.
[37] Y. Nakamura,et al. Putative tumor-suppressor gene on chromosome 11 is important in sporadic endocrine tumor formation. , 1993, American journal of surgery.
[38] R. Thakker,et al. Multiple endocrine neoplasia type 1 (MEN1). , 1994, European journal of cancer.
[39] B. Scheithauer,et al. ras mutations in human prolactinomas and pituitary carcinomas. , 1994, The Journal of clinical endocrinology and metabolism.
[40] G. Faglia,et al. Cellular alterations in pituitary tumors. , 1994, European journal of endocrinology.
[41] T. Sano,et al. Analysis of the Gs α gene in growth hormone-secreting pituitary adenomas by the polymerase chain reaction-direct sequencing method using paraffin-embedded tissues , 1993 .
[42] V. Cryns,et al. The retinoblastoma gene in human pituitary tumors. , 1993, The Journal of clinical endocrinology and metabolism.
[43] E. Friedman,et al. Activating mutations of the Gs alpha-gene in nonfunctioning pituitary tumors. , 1993, The Journal of clinical endocrinology and metabolism.
[44] S. Atkin,et al. Basic fibroblastic growth factor stimulates prolactin secretion from human anterior pituitary adenomas without affecting adenoma cell proliferation. , 1993, The Journal of clinical endocrinology and metabolism.
[45] Aldons J. Lusis,et al. Molecular basis of the little mouse phenotype and Implications for cell type-specific growth , 1993, Nature.
[46] S. Melmed,et al. Molecular screening of pituitary adenomas for gene mutations and rearrangements. , 1993, The Journal of clinical endocrinology and metabolism.
[47] R. Thakker,et al. Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations. , 1993, The Journal of clinical investigation.
[48] M. Brandi,et al. Increased basic fibroblast growth factor in plasma from multiple endocrine neoplasia type 1: relation to pituitary tumor. , 1993, The Journal of clinical endocrinology and metabolism.
[49] K. Matsumoto,et al. Identification and characterization of high molecular weight forms of basic fibroblast growth factor in human pituitary adenomas. , 1992, The Journal of clinical endocrinology and metabolism.
[50] S. Asa,et al. Transforming growth factor-α in normal and neoplastic human endocrine tissues , 1992 .
[51] G. Faglia,et al. G protein oncogenes in pituitary tumors , 1992, Trends in Endocrinology & Metabolism.
[52] W. Young,et al. Octreotide treatment of acromegaly. A randomized, multicenter study. , 1992, Annals of internal medicine.
[53] E. Hedley‐Whyte,et al. Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing's disease. , 1992, The Journal of clinical endocrinology and metabolism.
[54] R. Weinberg,et al. Effects of an Rb mutation in the mouse , 1992, Nature.
[55] X. Bertagna,et al. Monoclonality of corticotroph macroadenomas in Cushing's disease. , 1992, The Journal of clinical endocrinology and metabolism.
[56] C. Francomano,et al. Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[57] E. Hedley‐Whyte,et al. Ras mutations in human pituitary tumors. , 1992, The Journal of clinical endocrinology and metabolism.
[58] M. Merino,et al. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. , 1991, The New England journal of medicine.
[59] E. Oldfield,et al. Clonal composition of pituitary adenomas in patients with Cushing's disease: determination by X-chromosome inactivation analysis. , 1991, The Journal of clinical endocrinology and metabolism.
[60] J. Fagin,et al. Transforming DNA sequences present in human prolactin-secreting pituitary tumors. , 1991, Molecular endocrinology.
[61] B. Vogelstein,et al. p53 mutations in human cancers. , 1991, Science.
[62] P. Sawchenko,et al. Somatotroph hypoplasia and dwarfism in transgenic mice expressing a non-phosphorylatable CREB mutant , 1991, Nature.
[63] J. Norton,et al. Allelic loss on chromosome 11 in hereditary and sporadic tumors related to familial multiple endocrine neoplasia type 1. , 1991, Cancer research.
[64] K. Kovacs,et al. Clonal origin of pituitary adenomas. , 1990, The Journal of clinical endocrinology and metabolism.
[65] M. Arosio,et al. Clinical, biochemical, and morphological correlates in patients bearing growth hormone-secreting pituitary tumors with or without constitutively active adenylyl cyclase. , 1990, The Journal of clinical endocrinology and metabolism.
[66] H. Bourne,et al. Clinical characteristics of acromegalic patients whose pituitary tumors contain mutant Gs protein. , 1990, The Journal of clinical endocrinology and metabolism.
[67] S. Rubin,et al. Point mutations of ras oncogenes are an early event in thyroid tumorigenesis. , 1990, Molecular endocrinology.
[68] E. Kawasaki,et al. Two G protein oncogenes in human endocrine tumors. , 1990, Science.
[69] E. Clementi,et al. A new constitutively activating mutation of the Gs protein alpha subunit-gsp oncogene is found in human pituitary tumours. , 1990, Oncogene.
[70] A. Arnold,et al. Clinically nonfunctioning pituitary tumors are monoclonal in origin. , 1990, The Journal of clinical investigation.
[71] C. Larsson,et al. Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[72] M. Brandi,et al. Circulating fibroblast growth factor-like substance in familial multiple endocrine neoplasia type 1. , 1990, The Journal of clinical endocrinology and metabolism.
[73] L. Liotta,et al. Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. , 1989, Cancer research.
[74] J. L. Bos,et al. ras oncogenes in human cancer: a review. , 1989, Cancer research.
[75] H. Bourne,et al. GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumours , 1989, Nature.
[76] P. Bouloux,et al. Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. , 1989, The New England journal of medicine.
[77] Y. Nakamura,et al. Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. , 1989, The New England journal of medicine.
[78] A. Paterson,et al. Transforming Growth Factor-α Expression in the Anterior Pituitary Gland: Regulation by Epidermal Growth Factor and Phorbol Ester in Dispersed Cells , 1989 .
[79] T. Sano,et al. Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations. , 1988, Endocrine reviews.
[80] W. Lee,et al. Inactivation of the retinoblastoma susceptibility gene in human breast cancers. , 1988, Science.
[81] J. Yokota,et al. Human HST1 (HSTF1) gene maps to chromosome band 11q13 and coamplifies with the INT2 gene in human cancer. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[82] C. Larsson,et al. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma , 1988, Nature.
[83] G. Giannattasio,et al. Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas , 1987, Nature.
[84] S. Asa,et al. Alpha-transforming growth factor in the bovine anterior pituitary gland: secretion by dispersed cells and immunohistochemical localization. , 1987, Endocrinology.
[85] H. Willard,et al. Clonal analysis using recombinant DNA probes from the X-chromosome. , 1987, Cancer research.
[86] D. Gospodarowicz,et al. Structural characterization and biological functions of fibroblast growth factor. , 1987, Endocrine reviews.
[87] D. Goeddel,et al. Synthesis of Messenger RNAs for Transforming Growth Factors α and β and the Epidermal Growth Factor Receptor by Human Tumors , 1987 .
[88] M. Kobrin,et al. Alpha-transforming growth factor secreted by untransformed bovine anterior pituitary cells in culture. I. Purification from conditioned medium. , 1986, The Journal of biological chemistry.
[89] M. Kobrin,et al. Alpha-transforming growth factor secreted by untransformed bovine anterior pituitary cells in culture. II. Identification using a sequence-specific monoclonal antibody. , 1986, The Journal of biological chemistry.
[90] Stephen H. Friend,et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma , 1986, Nature.
[91] L. Swanson,et al. Growth hormone-releasing factor stimulates proliferation of somatotrophs in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[92] D. Gospodarowicz,et al. Fibroblast growth factor , 1986, Molecular and Cellular Endocrinology.
[93] T. Sugimura,et al. Transforming gene from human stomach cancers and a noncancerous portion of stomach mucosa. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[94] N. Ling,et al. A nonmitogenic pituitary function of fibroblast growth factor: regulation of thyrotropin and prolactin secretion. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[95] J. Hurley,et al. Sequence of the alpha subunit of photoreceptor G protein: homologies between transducin, ras, and elongation factors. , 1985, Science.
[96] S. Asa,et al. Cushing's disease associated with an intrasellar gangliocytoma producing corticotrophin-releasing factor. , 1984, Annals of internal medicine.
[97] N. Ling,et al. Isolation and partial molecular characterization of pituitary fibroblast growth factor. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[98] K. Kovacs,et al. Ectopic secretion of corticotropin-releasing factor as a cause of Cushing's syndrome. A clinical, morphologic, and biochemical study. , 1984, The New England journal of medicine.
[99] A. Knudson. Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.
[100] D. Nelson,et al. ACTH-producing pituitary tumors following adrenalectomy for Cushing's syndrome. , 1960, Annals of internal medicine.